Lithium treatment and risk of suicidal behavior in bipolar disorder patients

Journal of Clinical Psychiatry

Volumn 59, Issue 8, 1998, Pages 405-414

  Tondo, Leonardo ^a,b   Baldessarini, Ross J ^b,d   Hennen, John ^b   Floris, Gianfranco ^a   Silvetti, Francesco ^a   Tohen, Mauricio ^b,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MORTALITY; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SURVIVAL RATE;

EID: 0031846536     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0802     Document Type: Article

References (75)

1. Goodwin FK, Jamison KR. In: Manie-Depressive Illness. New York, NY: Oxford University Press; 1990: chap 10, 22, 23
2. Angst J, Stassen HH, Gross G. et al. Suicide in affective and schizoaffective disorders. In: Marneros A, Tsuang MT, eds. Affective and Schizoaffective Disorders. Berlin, Germany: Springer-Verlag; 1990:168-185
3. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry 1996;39:896-899
4. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness. Soc Psychiatry Psychiatr Epidemiol 1995;30:213-219
5. Gunell D, Frankel S. Prevention of suicide: aspirations and evidence. BMJ 1994;308:1227-1233
6. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 1993;3:186-212
7. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995;310: 215-218
8. Crundwell JK. Lithium and its potential benefit in reducing increased mortality rates due to suicide. Lithium 1994;5:193-204
9. Tondo L, Baldessarini RJ, Floris G, et al. Lithium maintenance treatment reduces risk of suicidal behavior in bipolar disorder patients. In: Gallicchio VS, Birch NJ, eds. Lithium: Biochemical and Clinical Advances. Cheshire, Conn: Weidner Publishing Group; 1996:161-171
10. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium on suicide risk in bipolar disorder patients. Ann N Y Acad Sci 1997;836:339-351
11. Baldessarini RJ, Tondo L. Antisuicidal effect of lithium treatment in major mood disorders. In: Jacobs D, ed. Harvard Medical School Guide to Assessment and Intervention in Suicide. San Francisco, Calif: Jossey Bass Division of Simon & Schuster. In press
12. Prien RF, Klett CJ, Caffey CM. Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 1974;131:198-203
13. Poole AJ, James HD, Hughes WC. Treatment experiences in the lithium clinic at St. Thomas Hospital. J R Soc Med 1978;71:890-894
14. Weeke A. Causes of death in manic-depressives. In: Schou M, Strömgren E, eds. Prevention and Treatment of Affective Disorders. London, England: Academic Press; 1979:289-299
15. Venkoba-Rao A, Hariharasubramanian N, Parvathi-Devi S, et al. Lithium prophylaxis in affective disorder. Indian J Psychiatry 1982;23:22-30
16. Hanus K, Zalpetálek M. Suicidal activity of patients with affective disorders in the course of lithium prophylaxis. Ceskoslovenská Psychiatrie 1984;80:97-100
17. Lepkifker E, Horesh N, Floru S. Long-term lithium prophylaxis in recurrent unipolar depression: a controversial indication? Acta Psychiatr Belg 1985;85:434-443
18. Müller-Oerlinghausen B, Müser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992;25:261-270
19. Coppen A. Depression as a lethal disease: prevention strategies. J Clin Psychiatry 1994;55(suppl 4):37-45
20. Lenz G. Increased mortality after drop-out from lithium clinic. Neuropsychopharmacology 1994;10(suppl 3, pt 1):682S
21. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, et al. Effect of prophylactic treatment on suicidal risk in patients with major affective disorders. Pharmacopsychiatry 1996;29:103-107
22. Barraclough B, Bunch J, Nelson B, et al. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974;125:355-373
23. Kay DWK, Petterson U. Manic-depressive illness. Acta Psychiatr Scand 269(suppl):55-60
24. Jamison KR. Suicide and bipolar disorders. Ann N Y Acad Sci 1986;487: 301-315
25. Coppen A, Standish-Barry H, Bailey J, et al. Does lithium reduce mortality of recurrent mood disorders? J Affect Disord 1991;23:1-7
26. Modestin J, Schwartzenbach F. Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatr Scand 1992; 85:173-175
27. Nilsson A. Mortality in a lithium-treated population with mood disorders. Clin Neuropharmacol 1992;15(suppl 1):448B
28. Sharma R, Markar HR. Mortality in affective disorder. J Affect Disord 1994;31:91-96
29. Ahrens B, Müller-Oerlinghausen B, Schou M, et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995;33:67-75
30. Ahrens B, Müller-Oerlinghausen B, Wolf T, et al. Mortality during initial and later lithium treatment. Acta Psychiatr Scand 1994;90:295-297
31. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium: a complete population study in 362 patients. Pharmacopsychiatry 1995;28:8-13
32. Norton B, Whalley LJ. Mortality of a lithium treatment population. Br J Psychiatry 1984;145:277-282
33. Vestergaard P, Aagaard J. Five-year mortality in lithium-treated manic-depressive patients. J Affect Disord 1991;21:33-38
34. Müller-Oerlinghausen B, Ahrens B, Grof E, et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992;86:218-222
35. Angst J, Stassen HH, Angst F. Excess mortality in psychiatric populations: methodological issues and empirical results. Neuropsychopharmacology 1994;10(suppl 3,pt 1):683S
36. Isometsä ET, Henricksson MM, Ara HM, et al. Suicide in bipolar disorder in Finland. Am J Psychiatry 1994;151:1020-1024
37. Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 1996;153:993-1000
38. Suppes T, Baldessarini RJ, Faedda GL, et al. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082-1088
39. Faedda GL, Tondo L, Baldessarini RJ, et al. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar mood disorders. Arch Gen Psychiatry 1993;50:448-455
40. Suppes T, Baldessarini RJ, Faedda GL, et al. Discontinuing maintenance treatment in bipolar manic-depression: risks and implications. Harv Rev Psychiatry 1993;1:131-144
41. Baldessarini RJ, Suppes T, Tondo L. Lithium withdrawal in bipolar disorder: implications for clinical practice and experimental therapeutics research. Am J Ther 1996;3:492-496
42. Baldessarini RJ, Tondo L, Faedda GL, et al. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry 1996;57:441-448
43. Tondo L, Baldessarini RJ, Floris G. Effectiveness of lithium maintenance treatment in types I and II bipolar disorder. Am J Psychiatry. In press
44. Dwyer J, Feinlieb M. Introduction to statistical models for longitudinal observations. In: Dwyer J, Feinlieb M, Lippert P, et al, eds. Statistical Models for Longitudinal Studies of Health. New York, NY: Oxford University Press; 1992:3-48
45. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22
46. Collett D. Modelling Survival Data in Medical Research. London, England: Chapman & Hall; 1994:35-44
47. Maj M, Starace F, Nolfe G, et al. Minimum plasma lithium levels required for effective prophylaxis in DSM-III bipolar disorder: a prospective study. Pharmacopsychiatry 1986;19:420-423
48. Johnson DF, Hunt G. Suicidal behavior in bipolar manic-depressive patients and their families. Compr Psychiatry 1979;20:159-164
49. Roy-Byrne PP, Post RM, Hambrick DD, et al. Suicide and course of illness in major affective disorder. J Affect Disord 1988;15:1-8
50. Malone KM, Haas GL, Sweeney JA, et al. Major depression and the risk of attempted suicide. J Affect Disord 1995;34:173-185
51. Müller-Oerlinghausen B, Wolf B, Ahrens B, et al. Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-Treated Patients. Acta Psychiatr Scand 1996;94:344-347
52. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: Molecular targets for lithium's actions. Arch Gen Psychiatry 1995;42:531-543
53. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: antimanic and antidepressant agents. In: Harden W, Rudin W, Molinoff PB, et al, eds. Goodman and Oilman's The Pharmacologic Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill Press; 1996:431-459
54. Mann JJ, Arango V, Underwood MD. Serotonin and suicidal behavior. Ann N Y Acad Sci 1986;600:476-485
55. Åsberg M, Schalling D, Traskman-Bendz L, et al. Psychobiology of suicide, impulsivity, and related phenomena. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:655-668
56. Wickham EA, Reed JV. Lithium for the control of aggressive and self-mutilating behavior. Int Clin Psychopharmacol 1987;2:181-190
57. Tyrer SP. Lithium in aggression. In: Birch NJ, ed. Lithium: Inorganic Pharmacology and Psychiatric Use. Oxford, England: IRL Press; 1988:39-42
58. Price LH, Chamey DS, Delgado PL, et al. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 1990;100:3-12
59. Linnoila VMI, Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry 1992;53(10, suppl):46-51
60. Montgomery SA, Montgomery DB, Green M, et al. Pharmacotherapy in the prevention of suicidal behavior. J Clin Psychopharmacol 1992;12 (suppl 2):27S-31S
61. Johnson DF, Hunt G. Suicidal behavior in bipolar manic-depressive patients and their families. Compr Psychiatry 1979;20:159-164
62. Roy-Byrne PP, Post RM, Hambrick DD, et al. Suicide and course of illness in major affective disorder. J Affect Disord 1988;15:1-8
63. Faedda GL, Baldessarini RJ, Suppes T, et al. Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry 1995;3:171-195
64. Baldessarini RJ, Tondo L, Suppes T, et al. Pharmacological treatment of bipolar disorder throughout the life-cycle. In: Shulman KI, Tohen M, Kutcher S, eds. Bipolar Disorder Through the Life-Cycle. New York, NY: John Wiley & Sons; 1996:299-338
65. Kukopoulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-167
66. Zornberg G, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408
67. Kelleher MJ, Daly M, Kelleher MJA. The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. Br J Psychiatry 1992;161:625-628
68. Freemantle N, House A, Song F, et al. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ 1994;309: 249-253
69. Isacsson G, Holmgren P, Wasserman D, et al. Use of antidepressants among people committing suicide in Sweden. BMJ 1994;308:506-509
70. Ohberg A, Lonqvist J, Sarna S, et al. Trends and availability of suicide methods in Finland: proposals for restrictive measures. Br J Psychiatry 1995;166:35-43
71. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;11:1403-1411
72. Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549-550
73. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-393
74. Swann AC, Bowden CL, Morris D, et al. Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997;54: 37-42
75. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135